PET scans in radiotherapy planning of lung cancer

Lung Cancer

Volumn 75, Issue 2, 2012, Pages 141-145

  De Ruysscher, Dirk ^a   Nestle, Ursula ^b   Jeraj, Robert ^c   MacManus, Michael ^d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Delineation; Lung cancer; PET; Planning; Radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84855471335     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.07.018     Document Type: Review

References (42)

1. Boellaard R., Oyen W.J., Hoekstra C.J., Hoekstra O.S., Visser E.P., Willemsen A.T., et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008, 35:2320-2333.
2. Hellwig D., Baum R.P., Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin 2009, 48:59-69.
3. Weber W.A. Quantitative analysis of PET studies. Radiother Oncol 2010, 96:308-310.
4. Sattler B., Lee J.A., Lonsdale M., et al. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol 2010, 96:288-297.
5. Dooms C., Verbeken E., Stroobants S., et al. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. J Clin Oncol 2008, 26:1128-1134.
6. De Ruysscher D., Faivre-Finn C., Nestle U., et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. J Clin Oncol 2010, 28(November):5301-5310. [Epub ahead of print].
7. Nestle U., Kremp S., Grosu A.L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006, 81:209-225.
8. Nestle U., Schaefer-Schuler A., Kremp S., et al. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007, 34:453-462.
9. 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small cell lung cancer (NSCLC): a modelling study. Int J Radiat Oncol Biol Phys 2005, 61:648-654.
10. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: results of a prospective study. Radiother Oncol 2005, 77:5-10.
11. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2005, 62:988-994.
12. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:126-134.
13. Sura S., Greco C., Gelblum D., et al. (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:1397-1402.
14. Erdi Y.E., Mawlawi O., Larson S.M., et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997, 80(12 Suppl):2505-2509.
15. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005, 46:1342-1348.
16. van Baardwijk A., Bosmans G., Boersma L., et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007, 68:771-778.
17. Stroom J., Blaauwgeers H., van Baardwijk A., et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys 2007, 69:267-275.
18. Nestle U., Walter K., Schmidt S., et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999, 44:593-597.
19. Schaefer A., Kremp S., Hellwig D., et al. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging 2008, 35:1989-1999.
20. Lee J.A. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol 2010, 96:302-307.
21. Bayne M., Hicks R.J., Everitt S., et al. Reproducibility of intelligent contouring o gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. Int J Radiat Oncol Biol Phys 2010, 77:1151-1157.
22. Grgic A., Nestle U., Schaefer-Schuler A., et al. FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning - an intraindividual comparison. Int J Radiat Oncol Biol Phys 2009, 73:103-111.
23. Nehmeh S.A., Erdi Y.E., Rosenzweig K.E., et al. Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET. J Nucl Med 2003, 44:1644-1648.
24. Mac Manus M.P., Hicks R.J., Ball D.L., et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001, 92:886-895.
25. Kolodziejczyk M., Kepka L., Dziuk M., et al. Impact of [(18)F]Fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2011, 80:1008-1014.
26. Mac Manus M.P., Wong K., Hicks R.J., et al. Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int J Radiat Oncol Biol Phys 2002, 52:351-361.
27. van Baardwijk A., Wanders S., Boersma L., et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stage I-III non-small cell lung cancer. J Clin Oncol 2010, 28:1380-1386.
28. Aerts H.J., Bosmans G., van Baardwijk A.A., et al. Stability of (18)F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study. Int J Radiat Oncol Biol Phys 2008, 71:1402-1407.
29. Aerts H.J., van Baardwijk A.A., Petit S.F., et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 2009, 91:386-392.
30. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy in relation to metabolic response. A prospective study in locally advanced non-small cell lung cancer patients. Radiother Oncol 2007, 82:145-152.
31. MacManus M., Nestle U., Rosenzweig K.E., et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009, 91:85-94.
32. Everitt S., Hicks R.J., Ball D., et al. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009, 75(November (4)):1098-1104.
33. Brink I., Schumacher T., Mix M., et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004, 31:1614-1620.
34. Fischer B.M., Mortensen J., Langer S.W., et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 2007, 18:338-345.
35. Niho S., Fujii H., Murakami K., et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Lung Cancer 2007, 57:328-333.
36. Pandit N., Gonen M., Krug L., et al. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer. Eur J Nucl Med Mol Imaging 2003, 30:78-84.
37. Shen Y.Y., Shiau Y.C., Wang J.J., et al. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer. Anticancer Res 2002, 22:1257-1264.
38. Kamel E.M., Zwahlen D., Wyss M.T., et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003, 44:1911-1917.
39. De Ruysscher D., Bremer R.H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol 2006, 80:307-312.
40. 18FDG-PET scans in limited disease small cell lung cancer: a phase II trial. Int J Radiat Oncol Biol Phys 2010, 77:329-336.
41. van Loon J., Offermann C., Bosmans G., et al. (18)FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 2008, 87:49-54.
42. Everitt S., Herschtal A., Callahan J., et al. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer. Cancer 2010, 116:5030-5037.